-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation